Position in XGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,389,896
-$3,198,760 QoQ
Shares Held
796,632
-13.3% QoQ
Ownership
3.30%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Balyasny Asset Management L.P. holds $561,999,836 across 19 Diagnostics & Research names. XGN ranks #11 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
555,473 | $273,031,643 | |
| 2 | A |
Agilent Technologies, Inc.
|
662,943 | $75,562,243 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
47,948 | $60,472,017 | |
| 4 | DHR |
Danaher Corp /De/
|
198,596 | $37,653,801 | |
| 5 | TWST |
Twist Bioscience Corp
|
726,288 | $34,513,205 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
42,293 | $20,308,675 | |
| 7 | QGEN |
Qiagen N.V.
|
433,592 | $17,361,023 | |
| 8 | ICLR |
Icon PLC
|
136,416 | $15,095,794 |
All Filings in XGN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,389,896 | 796,632 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,588,656 | 919,187 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,950,473 | 723,428 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,017,098 | 718,782 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||